2016
DOI: 10.1038/mtna.2016.18
|View full text |Cite
|
Sign up to set email alerts
|

A Biofunctional Molecular Beacon for Detecting Single Base Mutations in Cancer Cells

Abstract: The development of a convenient and sensitive biosensing system to detect specific DNA sequences is an important issue in the field of genetic disease therapy. As a classic DNA detection technique, molecular beacon (MB) is often used in the biosensing system. However, it has intrinsic drawbacks, including high assay cost, complicated chemical modification, and operational complexity. In this study, we developed a simple and cost-effective label-free multifunctional MB (LMMB) by integrating elements of polymeri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 51 publications
0
7
0
Order By: Relevance
“…After phosphorylation at the 5′-end, ligase was added to catalyze the closure reaction between the 3′-and the 5′-ends of the ss to form C1 and CAP1. 35 The latter two hybridized each other to form the ds circular CAP1 (cCAP1), which possesses a unique capture arm (Region 1 that contains AP1 for targeting EpCAM; Figure S3b, Supporting Information) and a circular body (Region 2 as the steric hindrances to degradation; Figure S3b, Supporting Information). Figure 1f showed the structure of cCAP2, which is similar to that of cCAP1 except for the capture arm (Region 1; Figure S3c, Supporting Information) containing HB5 that targets biomarker Her2.…”
Section: Resultsmentioning
confidence: 99%
“…After phosphorylation at the 5′-end, ligase was added to catalyze the closure reaction between the 3′-and the 5′-ends of the ss to form C1 and CAP1. 35 The latter two hybridized each other to form the ds circular CAP1 (cCAP1), which possesses a unique capture arm (Region 1 that contains AP1 for targeting EpCAM; Figure S3b, Supporting Information) and a circular body (Region 2 as the steric hindrances to degradation; Figure S3b, Supporting Information). Figure 1f showed the structure of cCAP2, which is similar to that of cCAP1 except for the capture arm (Region 1; Figure S3c, Supporting Information) containing HB5 that targets biomarker Her2.…”
Section: Resultsmentioning
confidence: 99%
“…[89] The achieved LOD is also lower compared to the ones provided by molecular beacons labeled with organic dyes (LOD = 500 pM), [145] or label-free multifunctional molecular beacons (LOD = 250 pM). [146] 5 Polymer-encapsulated QDs were chosen to act as a FRET donor due to their exceptional brightness and good colloidal stability, and subsequently used as a carrier of label acceptor PNA probes. Highly hydrophilic and bright asymmetric tri-sulfo-Cy5 was selected for the role of FRET acceptor and subsequently used for the synthesis of label donor PNA probes.…”
Section: Comparison Of Qd-based Otr To Other Methods In the Fieldmentioning
confidence: 99%
“…The split G4 design can also be applied to the molecular beacon (MB) concept devoid of the fluorophore-quencher complex whilst maintaining their specific catalytic activity. MB was first reported in 1996 and has since been one of the most widely used systems for DNA biosensors [66,67]. Originally, the MB system alone relies on the concept of a closed to opened conformational change in the presence of a target DNA.…”
Section: G-quadruplex-based Detection Systemmentioning
confidence: 99%